ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

OMGA Omega Therapeutics Inc

2.5998
0.3698 (16.58%)
May 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 415,184
Bid Price 2.54
Ask Price 2.60
News -
Day High 2.59

Low
1.30

52 Week Range

High
10.09

Day Low 2.25
Share Name Share Symbol Market Stock Type
Omega Therapeutics Inc OMGA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.3698 16.58% 2.5998 18:58:24
Open Price Low Price High Price Close Price Previous Close
2.25 2.25 2.59 2.48 2.23
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
3,765 415,184 US$ 2.48 US$ 1,028,186 - 1.30 - 10.09
Last Trade Type Quantity Price Currency
18:58:24 formt 3,000 US$ 2.5998 USD

Omega Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
136.2M 55.14M - 3.09M -97.43M -1.77 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Omega Therapeutics News

Date Time Source News Article
4/23/202406:00GlobeNewswire Inc.Omega Therapeutics to Present New Preclinical Data on..
4/09/202406:00GlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data at AACR..
3/28/202408:15GlobeNewswire Inc.Omega Therapeutics Reports Fourth Quarter and Full Year 2023..
3/06/202406:00GlobeNewswire Inc.Omega Therapeutics Announces Two Poster Presentations at the..
2/09/202416:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/09/202416:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/09/202415:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/05/202415:00Edgar (US Regulatory)Form 8-K - Current report
1/02/202415:05GlobeNewswire Inc.Omega Therapeutics to Present at the 42nd Annual J.P. Morgan..
12/11/202315:00Edgar (US Regulatory)Form 8-K - Current report
12/04/202315:00GlobeNewswire Inc.Omega Therapeutics to Participate in the H.C. Wainwright 4th..
11/27/202318:01PR Newswire (US)Flagship Pioneering Marks Official Opening of UK Hub with..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No OMGA Message Board. Create One! See More Posts on OMGA Message Board See More Message Board Posts

Historical OMGA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.352.592.20012.30217,5780.249810.63%
1 Month3.013.232.20012.65299,519-0.4102-13.63%
3 Months3.664.45992.20013.52386,562-1.06-28.97%
6 Months1.446.301.304.621,222,8531.1680.54%
1 Year7.6610.091.304.61693,431-5.06-66.06%
3 Years22.1031.411.305.64320,749-19.50-88.24%
5 Years22.1031.411.305.64320,749-19.50-88.24%

Omega Therapeutics Description

Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease.

Your Recent History

Delayed Upgrade Clock